A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease. An intervention, ...
The human brain remains one of the most mysterious and unexplored frontiers. However, with the rapid development of science and technology, this is changing. The advancement of neurotechnologies, ...
BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics, a neurotechnology company developing graphene-based brain-computer interface therapeutics (BCI-Tx), today announced completion of patient ...
Traumatic brain injuries, including mild concussions, can trigger a chain reaction in the brain that disrupts neural ...
University of Pittsburgh School of Medicine researchers carrying out a small pilot clinical trial demonstrating that a drug-free, minimally invasive intervention targets the root cause of progressive ...
A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease. An intervention, ...
The study (NCT06368310), sponsored by the University of Manchester and conducted with Northern Care Alliance NHS Foundation Trust, evaluated INBRAIN’s graphene-based cortical interface during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results